[Cost-effect pharmacological studies of Parkinson's disease].
Chikina
E S
ES
Belousov
Iu B
IuB
D000367:Age Factors; D000978:Antiparkinson Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D014943:Global Health; D005102:Health Expenditures; D006296:Health Services / Q000191:economics* / Q000706:statistics & numerical data*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000191:economics*; D011788:Quality of Life
D000978:Antiparkinson Agents